Contribution to More Patient-Friendly ART Treatment: Efficacy of Continuous Low-Dose GnRH Agonist as the Only Luteal Support—Results of a Prospective, Randomized, Comparative Study

Table 2

IVF/ICSI cycle outcomes (mean ± SD).

	Group A; (buserelin 3x/day)	Group B; (micronized progesterone 3x/day)
Retrieved oocytes ()	10.1 ± 4.1	10.7 ± 5.9	NS
Cleaved embryos ()	5.8 ± 2.7	6.0 ± 3.2	NS
Transferred embryos ()	1.4 ± 0.5	1.4 ± 0.5	NS
Pregnancy rate/transfer	11/35; 31.4%	4/18; 22.2%	NS
Clinical pregnancy rate	9/35; 25.7%	3/18; 16.7%	NS
Implantation rate	11/50; 22%	4/26; 15.4%	NS